RU95116781A - METHOD FOR TREATING EPILEPSY PATIENTS - Google Patents

METHOD FOR TREATING EPILEPSY PATIENTS

Info

Publication number
RU95116781A
RU95116781A RU95116781/14A RU95116781A RU95116781A RU 95116781 A RU95116781 A RU 95116781A RU 95116781/14 A RU95116781/14 A RU 95116781/14A RU 95116781 A RU95116781 A RU 95116781A RU 95116781 A RU95116781 A RU 95116781A
Authority
RU
Russia
Prior art keywords
treating epilepsy
epilepsy patients
patients
treating
tyroliberin
Prior art date
Application number
RU95116781/14A
Other languages
Russian (ru)
Other versions
RU2118537C1 (en
Inventor
Л.М.Б. Асанова
И.П. Ашмарин
Н.Е. Чепурнова
С.А. Чепурнов
Original Assignee
Государственный Научный Центр социальной и судебной психиатрии им. В.П.Сербского
Filing date
Publication date
Application filed by Государственный Научный Центр социальной и судебной психиатрии им. В.П.Сербского filed Critical Государственный Научный Центр социальной и судебной психиатрии им. В.П.Сербского
Priority to RU95116781A priority Critical patent/RU2118537C1/en
Priority claimed from RU95116781A external-priority patent/RU2118537C1/en
Publication of RU95116781A publication Critical patent/RU95116781A/en
Application granted granted Critical
Publication of RU2118537C1 publication Critical patent/RU2118537C1/en

Links

Claims (1)

Способ лечения больных эпилепсией, заключающийся в комплексной терапии противосудорожными препаратами различных химических групп, отличающийся тем, что больному дополнительно интраназально вводят тиролиберин в дозе (0,5 - 1)10-8 г 2 раза в день в течение месяца.A method of treating patients with epilepsy, which consists in complex therapy with anticonvulsants of various chemical groups, characterized in that the patient is additionally intranasally injected with tyroliberin at a dose of (0.5 - 1) 10 -8 g 2 times a day for a month.
RU95116781A 1995-10-02 1995-10-02 Method of treatment of epileptic patients RU2118537C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU95116781A RU2118537C1 (en) 1995-10-02 1995-10-02 Method of treatment of epileptic patients

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU95116781A RU2118537C1 (en) 1995-10-02 1995-10-02 Method of treatment of epileptic patients

Publications (2)

Publication Number Publication Date
RU95116781A true RU95116781A (en) 1997-10-10
RU2118537C1 RU2118537C1 (en) 1998-09-10

Family

ID=20172473

Family Applications (1)

Application Number Title Priority Date Filing Date
RU95116781A RU2118537C1 (en) 1995-10-02 1995-10-02 Method of treatment of epileptic patients

Country Status (1)

Country Link
RU (1) RU2118537C1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2538724C1 (en) * 2013-12-19 2015-01-10 Федеральное государственное унитарное предприятие "Государственный научно-исследовательский институт особо чистых биопрепаратов" Федерального медико-биологического агентства Method of treating epilepsy

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2538724C1 (en) * 2013-12-19 2015-01-10 Федеральное государственное унитарное предприятие "Государственный научно-исследовательский институт особо чистых биопрепаратов" Федерального медико-биологического агентства Method of treating epilepsy

Similar Documents

Publication Publication Date Title
FR2703254B1 (en) Device for the therapeutic treatment of pathological tissue, comprising a catheter.
CA2149329A1 (en) Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma
UA32429C2 (en) Agent for treatment of patient with enuresis
TW376320B (en) Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
NL1003300A1 (en) Implantable therapeutic device.
NZ504026A (en) Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C
EP0671920A4 (en) An anti-idiotypic antibody and its use in diagnosis and in therapy in hiv-related disease.
LV11615A (en) Amid with medical treatment
BR9609176A (en) Compositions of biological agent
DE3886046D1 (en) SELF-BLUNTING NEEDLE UNIT AND THIS DEVICE.
FR2740978B1 (en) IMPLANTABLE DEFIBRILLATOR / CARDIOVERVER ACTIVE MEDICAL DEVICE
DE68908374D1 (en) PROPENONOXIMETHER, METHOD FOR THE PRODUCTION THEREOF AND THE MEDICINAL PRODUCTS CONTAINING THEM.
KR950700726A (en) Composition for treatment or diagnosis, its manufacturing method and use (COMPOSITION FOR THERAPEUTIC OR DIAGNOSTIC USE, PROCESS FOR ITS PREPARATION AND ITS USE)
NO911429D0 (en) DRUG TREATMENT.
DE59605959D1 (en) Use of immunoglobulin preparations for the manufacture of a medicament for oral administration for the treatment and prophylaxis of chronic pain conditions
NO973589D0 (en) Medication for the treatment of obsessive compulsive problems, sleep apnea, sexual dysfunction, emesis and travel sickness
TR199600118A2 (en) Substituted benzolsulfonyl ureas and thioureas, the method, drug or diagnostic use for their manufacture and medicament containing them.
ATE64531T1 (en) TUMOR THERAPY AND PROCESS FOR ITS PRODUCTION.
UA42685C2 (en) Method of the vasodilator therapy
DE3677637D1 (en) THERAPEUTIC AND PREVENTIVE AGENTS AGAINST STOMACH, ITS COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF.
EP0744176A3 (en) Methods for inhibiting bone loss
RU95116781A (en) METHOD FOR TREATING EPILEPSY PATIENTS
DE58904595D1 (en) NEW ALKYLPHOSPHONOSERINE, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL AGENT CONTAINING IT.
ZA964198B (en) Treatment regime for skin.
NZ306122A (en) Rage tumour rejection antigen precursors, diagnosis and treatment thereby